蛋白質鑑定市場－全球產業規模、佔有率、趨勢、機會、預測：按產品/服務、應用、最終用途、地區和競爭格局分類，2021-2031年

全球蛋白質鑑定市場預計將從 2025 年的 67.7 億美元大幅成長至 2031 年的 141.8 億美元，複合年成長率為 13.11%。

蛋白質鑑定是指辨識生物樣本中蛋白質的胺基酸序列和功能特性，主要採用質譜和生物資訊等分析技術。該市場正在擴張，主要受全球慢性病發病率上升的推動，這催生了對新型生物標記的巨大需求，而這些生物標記對於精準的臨床診斷和治療監測至關重要。此外，政府對生命科學研究的大量投入以及對個人化醫療日益成長的需求，為該領域的持續成長奠定了堅實穩定的基礎，而不是僅僅是暫時的市場波動。然而，先進設備的高昂購置成本以及數據解讀的複雜學習曲線仍然是更廣泛市場准入的重要障礙。為了應對這些挑戰並展現技術的成熟度，人類蛋白質組組織在2025年報告稱，其人類蛋白質組計劃已成功檢驗了93.6%的預測人類蛋白質組的表達。這項成就證實了該行業分析複雜生物數據的能力，儘管由於先進分析的高成本，在資源匱乏的環境中，其應用仍然受到限制。

市場促進因素

製藥和生物技術領域研發投入的成長是全球蛋白質鑑定市場的主要驅動力。這是因為製藥公司正在加大蛋白質體學分析的投資，以加速產品研發進程。資金的激增直接轉​​化為先進分析儀器和生物資訊服務的採購增加，這些對於在藥物發現早期階段闡明複雜的蛋白質結構至關重要。資金籌措的增加使公司能夠克服在鑑定低表達蛋白和檢驗治療標靶方面的技術挑戰，從而提高臨床試驗的成功率。例如，諾和諾德公司於2025年2月發布的2024年度報告顯示，其研發支出成長了48%，達到481億丹麥克朗，反映出依賴蛋白質分析的研究活動正在強勁成長。生物製藥和單株抗體的加速發展也進一步推動了市場需求，因為這些大分子治療藥物比小分子藥物需要更嚴格的鑑定和品管流程。監管機構目前強制要求對新型生物製藥進行全面的蛋白質體學分析，以確保其安全性和有效性，加速了高解析度質譜和胜肽圖譜技術的應用。監管措施進一步強化了這一趨勢。美國食品藥物管理局（FDA）於2025年1月發布的《2024年新藥核准報告》顯示，當年核准了50種新藥，其中許多是需要廣泛蛋白質表徵的生物製藥。丹納赫公司2024年全年銷售額達239億美元（數據於2025年公佈），這為其在生命科學和診斷工具領域的強大商業基礎提供了強力的支撐，也為支撐整個生態系統的強大分析基礎設施提供了有力支撐。

市場挑戰

先進設備所需的大量資本投入，以及掌握資料解讀過程的耗時性，是全球蛋白質鑑定市場擴張的主要障礙。高解析度質譜系統是精準發現生物標記的關鍵，但其前期投入龐大，對於資源有限的小規模臨床檢查室和醫療機構而言，往往難以實施。這種資金限制實際上將先進蛋白質鑑定技術的應用範圍限制在資金雄厚的學術機構和大型製藥公司，阻礙了其在高通量臨床診斷領域的市場滲透，而成本效益正是該領域的首要考慮因素。此外，蛋白質體學數據分析固有的技術複雜性也造成了嚴重的營運瓶頸。這個過程需要高度專業的人員從生物噪音中識別有效訊號，而這項工作仍然耗費大量資源且難以規模化。這種技術難題在業界持續努力全面繪製複雜生物樣本圖譜的過程中得到了充分體現。根據人類蛋白質體組織（HPO）的數據，截至2024年，儘管全球研究人員付出了許多努力，仍有1273種蛋白質被歸類為“未鑑定蛋白質”，這凸顯了分析方面持續存在的挑戰，以及實現蛋白質組學完整可視化所需的大量資源。這種持續的複雜性導致高昂的營運成本，並直接阻礙了蛋白質鑑定從研究工具向常規醫療應用的轉變。

市場趨勢

空間蛋白質體學與成像質譜技術的融合正在從根本上改變市場格局，將蛋白質分析從整體定量轉向組織微環境中的精確定位。這種原位繪製異質性圖譜的能力對於理解癌症等複雜疾病至關重要，推動著從傳統的基於勻漿的工作流程向能夠保留組織學背景的高解析度空間解析度技術轉變。儀器製造商正透過推出高通量成像平台來滿足這一需求，這些平台彌合了顯微鏡和深度蛋白質組學分析之間的差距。布魯克公司於2025年2月發布的2024會計年度第四季及全年財報反映了這項技術拓展的商業性成功，數據顯示，該公司2024會計年度營收達到33.7億美元，這主要得益於其空間生物學和先進質譜解決方案的加速應用。同時，與多體學研究平台的整合代表著一項重要的結構性變革：蛋白質鑑定擴大與基因組和轉錄組分析並行進行，以建立全面的分子圖譜。這一趨勢要求開發能夠整合不同資料層的互操作系統，從而促進策略整合和跨學科夥伴關係，增強蛋白質體學資料在系統生物學應用中的效用。專注於多模態產品和服務的公司業績強勁，清楚地體現了這種整合方法的經濟可行性。 Standard BioTools於2025年2月發布的2024年第四季及全年財報顯示，其總銷售額（總合計算）達1.751億美元，證明了該公司專注於高通量儀器以支援這些複雜的多體學研究工作流程的策略是正確的。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球蛋白質鑑定市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品/服務（耗材、設備、服務）分類
  • 按應用領域（藥物發現與開發、臨床診斷、其他）
  • 依最終用途分類（製藥和生物技術公司、學術研究機構、受託研究機構、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美蛋白質鑑定市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲蛋白質鑑定市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區蛋白質鑑定市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲蛋白質鑑定市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲蛋白質鑑定市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球蛋白質鑑定市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGAA
• Promega Corporation
• Qiagen NV
• Sartorius AG

第16章 策略建議

第17章：關於研究公司及免責聲明

The global market for protein identification is anticipated to grow substantially, increasing from USD 6.77 billion in 2025 to USD 14.18 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 13.11%. Protein identification encompasses analytical methods, chiefly mass spectrometry and bioinformatics, used to ascertain the amino acid sequence and functional identity of proteins within biological samples. This market expansion is primarily propelled by the escalating global incidence of chronic diseases, which creates a critical demand for novel biomarkers essential for precise clinical diagnosis and therapeutic monitoring. Moreover, significant government investment in life sciences research and the growing need for personalized medicine provide a strong, stable foundation for sustained growth, rather than temporary shifts in adoption.However, high capital costs for advanced instrumentation and the complex learning curve associated with data interpretation present notable barriers to broader market access. Counteracting these challenges and demonstrating technological maturity, the Human Proteome Organization reported in 2025 that the Human Proteome Project successfully validated the expression of 93.6% of the predicted human proteome. This achievement underscores the industry's capacity to analyze intricate biological data, even as the expense of such sophisticated analysis continues to restrict its adoption in settings with limited resources.

Market Driver

Increased spending on pharmaceutical and biotechnology research and development acts as a primary catalyst for the Global Protein Identification Market, as drug developers boost investments in proteomic characterization to expedite pipeline advancement. This financial surge directly leads to greater procurement of sophisticated analytical instruments and bioinformatics services, essential for mapping complex protein structures during early drug discovery. Enhanced funding enables companies to overcome technical hurdles in identifying low-abundance proteins and validating therapeutic targets, thereby improving success rates in clinical trials. For instance, Novo Nordisk's Annual Report 2024, released in February 2025, indicated a 48% increase in research and development costs to DKK 48.1 billion, reflecting aggressive scaling of research activities that depend on robust protein analysis.The escalating development of biologics and monoclonal antibodies further drives market demand, as these large-molecule therapeutics necessitate stringent identification and quality control processes beyond those required for small-molecule drugs. Regulatory bodies now mandate comprehensive proteomic profiling to ensure the safety and efficacy of new biologics, accelerating the adoption of high-resolution mass spectrometry and peptide mapping technologies. This trend is reinforced by regulatory actions; the FDA's January 2025 report on 'Novel Drug Approvals for 2024' noted approval for 50 novel drugs, many of which were biologics requiring extensive protein characterization. The substantial analytical infrastructure supporting this ecosystem is underscored by Danaher Corporation's full-year 2024 revenues of $23.9 billion, reported in 2025, highlighting the robust commercial base for life sciences and diagnostic tools.

Market Challenge

The substantial capital outlay required for sophisticated instrumentation, coupled with the steep learning curve for data interpretation, represents the main obstacle to the expansion of the Global Protein Identification Market. High-resolution mass spectrometry systems, crucial for accurate biomarker discovery, demand considerable upfront investment that is frequently prohibitive for smaller clinical laboratories and healthcare environments with limited resources. This financial constraint effectively limits the adoption of advanced protein identification technologies to well-funded academic institutions and major pharmaceutical companies, preventing market penetration into the high-volume clinical diagnostics sector where cost-efficiency is a paramount operational requirement.Furthermore, the technical complexity inherent in analyzing proteomic data creates a significant operational bottleneck. This process necessitates highly specialized personnel capable of distinguishing valid signals from biological noise, a task that remains resource-intensive and challenging to scale. This technical difficulty is evident in the industry's ongoing struggle to comprehensively map complex biological samples. According to the Human Proteome Organization, in 2024, despite global research efforts, 1,273 proteins were still categorized as "missing proteins," emphasizing the persistent analytical challenges and high resource demands needed to achieve complete proteomic visibility. This sustained complexity maintains high operational costs and directly impedes the transition of protein identification from a research-grade tool to a routine medical application.

Market Trends

The integration of spatial proteomics and imaging mass spectrometry is fundamentally transforming the market by shifting protein analysis from bulk quantification to precise localization within the tissue microenvironment. This ability to map heterogeneity in situ is vital for understanding complex diseases like cancer, driving a move from traditional homogenate-based workflows to spatially resolved techniques that maintain histological context. Instrument manufacturers are capitalizing on this demand by introducing high-plex imaging platforms that bridge the gap between microscopy and deep proteomic profiling. Highlighting the commercial success of this technological expansion, Bruker Corporation's Fourth Quarter and Full Year 2024 Financial Results, reported in February 2025, showed full-year 2024 revenues of $3.37 billion, a performance significantly boosted by the accelerated adoption of its spatial biology and advanced mass spectrometry solutions.Simultaneously, the convergence with multi-omics research platforms signifies a crucial structural evolution, where protein identification is increasingly performed alongside genomic and transcriptomic analysis to create comprehensive molecular profiles. This trend necessitates the development of interoperable systems capable of unifying disparate data layers, fostering strategic consolidations and cross-disciplinary partnerships that enhance the utility of proteomic data in systems biology applications. The financial viability of this integrated approach is evident in the resilience of companies focusing on multi-modal offerings; Standard BioTools' Fourth Quarter and Full Year 2024 Financial Results, reported in February 2025, revealed a pro forma combined revenue of $175.1 million, validating its strategic emphasis on high-throughput instruments that support these complex, multi-omic research workflows.

Key Market Players

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGAA
• Promega Corporation
• Qiagen N.V.
• Sartorius AG

Report Scope

In this report, the Global Protein Identification Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Identification Market, By Product & Services

• Consumables
• Instruments
• Services

Protein Identification Market, By Application

• Drug Discovery & Development
• Clinical Diagnosis
• Others

Protein Identification Market, By End-Use

• Pharmaceuticals & Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Others

Protein Identification Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Identification Market.

Available Customizations:

Global Protein Identification Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Identification Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Services (Consumables, Instruments, Services)
  • 5.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
  • 5.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Protein Identification Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Services
  • 6.2.2. By Application
  • 6.2.3. By End-Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Protein Identification Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Services
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Canada Protein Identification Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Services
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Mexico Protein Identification Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Services
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-Use

7. Europe Protein Identification Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Services
  • 7.2.2. By Application
  • 7.2.3. By End-Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Protein Identification Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Services
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-Use
  • 7.3.2. France Protein Identification Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Services
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Protein Identification Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Services
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Protein Identification Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Services
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Protein Identification Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Services
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-Use

8. Asia Pacific Protein Identification Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Services
  • 8.2.2. By Application
  • 8.2.3. By End-Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Protein Identification Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Services
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Protein Identification Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Services
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-Use
  • 8.3.3. Japan Protein Identification Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Services
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-Use
  • 8.3.4. South Korea Protein Identification Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Services
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Protein Identification Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Services
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-Use

9. Middle East & Africa Protein Identification Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Services
  • 9.2.2. By Application
  • 9.2.3. By End-Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Protein Identification Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Services
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-Use
  • 9.3.2. UAE Protein Identification Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Services
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-Use
  • 9.3.3. South Africa Protein Identification Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Services
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-Use

10. South America Protein Identification Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Services
  • 10.2.2. By Application
  • 10.2.3. By End-Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Protein Identification Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Services
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Colombia Protein Identification Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Services
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-Use
  • 10.3.3. Argentina Protein Identification Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Services
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Protein Identification Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Agilent Technologies, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bio-Rad Laboratories, Inc.
• 15.3. Bruker Corporation
• 15.4. Thermo Fisher Scientific Inc.
• 15.5. Danaher Corporation
• 15.6. Merck KGAA
• 15.7. Promega Corporation
• 15.8. Qiagen N.V.
• 15.9. Sartorius AG

16. Strategic Recommendations

17. About Us & Disclaimer